Tower Research Capital LLC TRC Buys 6,169 Shares of Encompass Health Co. (NYSE:EHC)

Tower Research Capital LLC TRC raised its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 139.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,598 shares of the company's stock after purchasing an additional 6,169 shares during the period. Tower Research Capital LLC TRC's holdings in Encompass Health were worth $979,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in EHC. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Transce3nd LLC purchased a new stake in shares of Encompass Health during the 4th quarter worth about $40,000. CBIZ Investment Advisory Services LLC raised its holdings in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares during the period. Tompkins Financial Corp acquired a new position in Encompass Health during the fourth quarter valued at approximately $46,000. Finally, V Square Quantitative Management LLC increased its position in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after acquiring an additional 177 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. UBS Group increased their price target on Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a report on Monday. Royal Bank of Canada lifted their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday. KeyCorp raised their target price on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research note on Friday. William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Barclays upped their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $120.86.

Encompass Health Stock Up 0.5 %

Shares of EHC stock traded up $0.59 on Tuesday, hitting $115.91. The company's stock had a trading volume of 1,251,086 shares, compared to its average volume of 680,197. The stock has a market capitalization of $11.67 billion, a price-to-earnings ratio of 25.99, a P/E/G ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a fifty-two week low of $82.38 and a fifty-two week high of $117.47. The firm's fifty day moving average price is $100.35 and its 200-day moving average price is $98.71. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the business earned $1.12 EPS. The firm's revenue was up 10.6% compared to the same quarter last year. Research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.59%. The ex-dividend date of this dividend was Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is currently 14.05%.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.10% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.